Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military personnel; Issues related to the implementation of Public Law No: 118-50, Making emergency supplemental appropriations for the fiscal year ending September 30, 2024, and for other purposes
2026 · 1st Quarter (Jan 1 - Mar 31)
ONWARD MEDICAL, INC.
Filed by ALPEX INTERNATIONAL, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 16, 2026
- Income
- $10,000.00
- Expenses
- Not reported
- Registrant
- ALPEX INTERNATIONAL, LLC
- Client
- ONWARD MEDICAL, INC.
- Filing UUID
- 0fd5bab7-55f2-43fc-947c-71ccba20e3af
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military and civilian personnel; Issues related to the implementation of Public Law No: 118-50, Making emergency supplemental appropriations for the fiscal year ending September 30, 2024, and for other purposes
Issues related to the "Nairobi Protocol" tariff treatment that grants duty-free importation status to educational, scientific, and cultural materials - specifically expanding coverage to include articles for handicapped persons - 1121 of the Omnibus Trade and Competitiveness Act of 1988 (Pub. L. 100-418, 102 Stat. 1107) and Presidential Proclamation 5978 (54 FR 21187).
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.